The latest formula of COVID-19 vaccines recently showed up in local pharmacies. Experts predict it will become like the annual flu shot.

For four decades, John Galgiani, MD, has pioneered translational research and clinical care for Valley fever, a disease more common in Arizona than anywhere else.

More than 80% of the people who were eligible to receive a COVID-19 booster last fall did not. New research is identifying the reasons why.

Startup company Ancerix, which worked with Tech Launch Arizona to file patents and license its intellectual property, developed a toolkit of instruments for surgical hardware removal.

A new study led by researchers in the Mel and Enid Zuckerman College of Public Health, published in the journal Vaccine, identified why less than 20% of the eligible population received COVID-19 boosters in 2022.

The story lists CO Architects as the No. 7 architecture firm in Los Angeles and cites the Health Sciences Innovation Building in Tucson and the Biomedical Sciences Partnership Building at the College of Medicine – Phoenix as two of its most prominent projects.

Nonprofit Campesinos Sin Fronteras was awarded $1.1 million to partner with the Prevention Research Center at the Mel and Enid Zuckerman College of Public Health and develop a structural intervention to promote health and prevent disease among migrant workers.

Researchers with the ongoing Arizona CoVHORT research study at the Mel and Enid Zuckerman College of Public Health were awarded $3.2 million for a five-year study of gastrointestinal symptoms, specifically irritable bowel syndrome, as a condition of long COVID.